Trial results simulator
Retatrutide
Retatrutide is an experimental peptide that activates three hormone receptors – GLP-1, GIP and glucagon – involved in appetite, blood sugar and energy use. Human trials have shown substantial weight loss. It remains investigational and is not yet approved for public use. The percentages measure total body weight lost, not body-fat percentage.
Your details
Trial results to apply
Weight over time
Tap a line or trial group to select it. Only the end-of-study averages come from the trials; the shape of the curve in between is an estimate.
All trial groups compared
Track your real progress
Log your weigh-ins and see them plotted against the trial averages. Your data is private to your account.
Log in to start tracking Create an accountSources
Important
Retatrutide is an investigational medicine – it is not approved for use outside clinical trials. This simulator shows the average results reported in clinical trials, where participants were selected, treated and monitored by doctors. It is not a prediction of your results and not medical advice – individual results vary widely. In the trials, the most common side effects were gastrointestinal (such as nausea, diarrhoea and vomiting). Do not use this tool to choose a dose. Always talk to a qualified healthcare professional.